Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus

NCT06886126 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: HDM1005 injection or placebo

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.